4-(Methylamino)cyclohexanone hydrochloride

Catalog No.: 
ACDXRT954
CAS No.: 
1260794-25-9
Molecular Formula: 
C7H14ClNO
Molecular Weight: 
163.65
4-(Methylamino)cyclohexanone hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$120.00InquiryInquiry
1g96%$271.00InquiryInquiry
5g96%$1328.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Methylamino)cyclohexanone hydrochloride
IUPAC Name4-(methylamino)cyclohexan-1-one hydrochloride
MDL No.MFCD11520360
Molecular FormulaC7H14ClNO
Molecular Weight163.65
SMILESO=C1CCC(NC)CC1.[H]Cl
InChI KeyNPFOMPKXKDTDFX-UHFFFAOYSA-N
Synonym4-(methylaMINO)CYCLOHEXANONE hydrochloride | 1260794-25-9 | 4-(METHYLAMINO)CYCLOHEXANONE HCL | Cyclohexanone, 4-(methylamino)-, hydrochloride (1:1) | 4-(methylamino)cyclohexan-1-one;hydrochloride | Cyclohexanone, 4-(methylamino)- | 4-(Methylamino)cyclohexanonehydroch
CAS No.1260794-25-9
PubChem CID46941496

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACDXRT954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTPMX029 route compound structure diagram
    ACTPMX029166398-41-0In Stock
  2. Then
  3. ACDXRT954 route product structure diagram
    ACDXRT9541260794-25-9
Inquiry

2. ACDXRT954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOTAF185 route compound structure diagram
    ACOTAF185400899-84-5In Stock
  2. Then
  3. ACDXRT954 route product structure diagram
    ACDXRT9541260794-25-9
Inquiry

3. ACDXRT954 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDXRT954 route product structure diagram
    ACDXRT9541260794-25-9
Inquiry

Comments (0)